Ignite Creation Date:
2024-05-06 @ 6:34 PM
Last Modification Date:
2024-10-26 @ 2:50 PM
Study NCT ID:
NCT05704738
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-09
First Post:
2023-01-20
Brief Title:
A Study to Evaluate Rocatinlimab AMG 451 in Adolescent Subjects With Moderate-to-severe Atopic Dermatitis AD
Sponsor:
Amgen
Organization:
Amgen
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-04-20
Start Date Type:
ACTUAL
Primary Completion Date:
2025-09-26
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-18
Completion Date Type:
ESTIMATED
First Submit Date:
2023-01-20
First Submit QC Date:
January 20 2023
Study First Post Date:
2023-01-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-24
Last Update Post Date:
2024-07-09
Last Update Post Date Type:
ACTUAL